Pichia kudriavzevii

Lore & Background

Pichia kudriavzevii plays a dual role: it is essential in chocolate production and is also an emerging pathogen. In chocolate making, cacao beans are fermented to remove bitterness and develop flavor, a process involving P. kudriavzevii and Geotrichum. These fungi are often naturally present on cacao seed pods and seeds, but specific strains are selected by chocolate companies for optimal flavor and aroma. The yeasts produce enzymes that break down the pulp on the outside of the beans and generate acetic acid, which kills the cacao embryo, develops a chocolatey aroma, and eliminates bitterness.

As a pathogen, P. kudriavzevii is most often found in patients who have had prior fluconazole exposure, sparking debate and conflicting evidence about whether fluconazole should be used prophylactically. Mortality due to P. kudriavzevii fungemia is much higher than that of the more common Candida albicans. Other Candida species that fit a similar profile include C. parapsilosis, C. glabrata, C. tropicalis, C. guillermondii, and C. rugosa.

Identification of P. kudriavzevii is aided by its growth characteristics: it grows on Sabouraud's dextrose agar as spreading colonies with a matte or rough whitish-yellow surface, in contrast to the convex colonies of Candida spp. This, together with its 'long grain rice' appearance on microscopy, helps definitive identification. Unlike other Candida species that generally require biotin for growth, P. kudriavzevii can grow in vitamin-free media.

Reader's Guide

Pichia kudriavzevii holds significance in two distinct fields: food production and clinical medicine. In chocolate production, it is indispensable for fermenting cacao beans, a process that removes bitterness and develops the characteristic chocolate aroma. The yeast's ability to produce enzymes that break down pulp and generate acetic acid is critical to this transformation. Each chocolate company uses proprietary strains selected for optimal flavor, underscoring its economic and cultural importance.

Clinically, P. kudriavzevii is an emerging nosocomial pathogen with natural resistance to fluconazole, a standard antifungal. This resistance, combined with its prevalence in immunocompromised patients and those with hematological malignancies, makes it a serious concern. The debate over prophylactic fluconazole use—given that prior exposure is common in infected patients—remains unresolved. Mortality from P. kudriavzevii fungemia is notably higher than from Candida albicans, highlighting its virulence. Effective treatments include voriconazole, amphotericin B, and echinocandins (micafungin, caspofungin, and anidulafungin). Its distinct growth characteristics on agar and microscopy aid in diagnosis, differentiating it from other Candida species that require biotin for growth.

Did You Know?

• Pichia kudriavzevii was formerly known as Candida krusei.
• It has natural resistance to fluconazole, a standard antifungal agent.
• It grows best at a temperature of 43–45 °C (109–113 °F).
• It can grow in vitamin-free media, unlike many other Candida species.